Zacks Investment Research on MSN8h
AMGN's Uplizna Gets FDA Nod for 2nd Rare Autoimmune Disease Indication
Amgen AMGN announced that the FDA has approved its rare disease drug Uplizna (inebilizumab) for a new indication. The ...
EMBO Press11h
Espin enhances confined cell migration by promoting filopodia formation and contributes to cancer metastasis
Espin induces abundant filopodia formation at the leading edge and along the sides, exerting force for cells migrating in ...
Amgen gets expanded FDA label approval for Uplizna
Amgen (NASDAQ: NASDAQ:AMGN) announced that the U.S. Food and Drug Administration (FDA) has granted an expanded label approval ...
BioMarin Pharmaceutical: Pegasus Success May Lead To Palynziq Label Expansion
BioMarin Pharmaceutical Inc. has advancements in phenylketonuria treatment. Click to learn how Palynziq's success could ...